{"id":3445,"date":"2024-04-03T15:28:08","date_gmt":"2024-04-03T13:28:08","guid":{"rendered":"https:\/\/www.unioviedo.es\/IUOPA\/?p=3445"},"modified":"2024-05-14T16:58:23","modified_gmt":"2024-05-14T14:58:23","slug":"a-personalized-medicine-approach-identifies-enasidenib-as-an-efficient-treatment-for-idh2-mutant-chondrosarcoma-2","status":"publish","type":"post","link":"https:\/\/www.unioviedo.es\/IUOPA\/en\/a-personalized-medicine-approach-identifies-enasidenib-as-an-efficient-treatment-for-idh2-mutant-chondrosarcoma-2\/","title":{"rendered":"A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-justify-content-center\" style=\"max-width:1216.8px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><style type=\"text\/css\">@media only screen and (max-width:1024px) {.fusion-title.fusion-title-1{margin-top:0px!important; margin-right:0px!important;margin-bottom:20px!important;margin-left:0px!important;}}@media only screen and (max-width:640px) {.fusion-title.fusion-title-1{margin-top:0px!important; margin-right:0px!important;margin-bottom:20px!important; margin-left:0px!important;}}<\/style><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"font-size:30px;margin-top:0px;margin-right:0px;margin-bottom:20px;margin-left:0px;\"><h1 class=\"title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:30;line-height:1.1;\">A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma<\/h1><\/div><div ><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-zoomin\"><a href=\"https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo.jpg\" class=\"fusion-lightbox\" data-rel=\"iLightbox[01a353ee0f40b6864cf]\" data-title=\"Publicaciones\" title=\"Publicaciones\"><img decoding=\"async\" width=\"1905\" height=\"607\" src=\"https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo.jpg\" data-orig-src=\"https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo.jpg\" alt class=\"lazyload img-responsive wp-image-1824\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271905%27%20height%3D%27607%27%20viewBox%3D%270%200%201905%20607%27%3E%3Crect%20width%3D%271905%27%20height%3D%27607%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-srcset=\"https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo-200x64.jpg 200w, https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo-400x127.jpg 400w, https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo-600x191.jpg 600w, https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo-800x255.jpg 800w, https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo-1200x382.jpg 1200w, https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo.jpg 1905w\" data-sizes=\"auto\" data-orig-sizes=\"(max-width: 1024px) 100vw, (max-width: 640px) 100vw, 1200px\" \/><\/a><\/span><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><div class=\"fusion-text fusion-text-1\"><p>Ver\u00f3nica Rey, Juan Torn\u00edn, Juan Jose Alba-Linares, Cristina Robledo, Dzohara Murillo, Aida Rodr\u00edguez, Borja Gallego, Carmen Huergo, Cristina Viera, Alejandro Bra\u00f1a, Aurora Astudillo, Dominique Heymann, Karoly Szuhai, Judith V.M.G. Bov\u00e9e, Agust\u00edn F. Fern\u00e1ndez, Mario F. Fraga, Javier Alonso and Ren\u00e9 Rodr\u00edguez. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma. eBioMedicine, 102:105090 (2024). doi: 10.1016\/j.ebiom.2024.105090. PMID: 38547578<\/p>\n<p><b>Consulta la publicaci\u00f3n en el siguiente <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352396424001257\" target=\"_blank\" rel=\"noopener\">enlace<\/a><\/b><\/p>\n<p><strong>Consulta el pdf de la publicaci\u00f3n en el siguiente <a href=\"https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2024\/04\/Rey-et-al-eBioMedicine-IDH2mut-2024.pdf\" target=\"_blank\" rel=\"noopener\">enlace<\/a><\/strong><\/p>\n<div class=\"voc-detail__cmp voc-detail__cmp--pad-lr \">\n<div class=\"voc-ficha-detail__wrapper\">\n<section class=\"voc-ficha-detail\">\n<div class=\"voc-list__wrapper\"><\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:100% !important;margin-top : 0px;margin-bottom : 0px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1024px) {.fusion-body .fusion-builder-column-0{width:75% !important;order : 0;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 2.56%;margin-left : 2.56%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;order : 0;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 0px;margin-top : 0px;padding-right : 30px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 30px;}@media only screen and (max-width:1024px) {.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 80px;}}<\/style><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1216.8px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 20px 0px 20px 0px;\"><div class=\"fusion-sharing-box fusion-sharing-box-1\" style=\"background-color:#f6f6f6;margin-top:60px;\" data-title=\"A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma\" data-description=\"Ver\u00f3nica Rey, Juan Torn\u00edn, Juan Jose Alba-Linares, Cristina Robledo, Dzohara Murillo, Aida Rodr\u00edguez, Borja Gallego, Carmen Huergo, Cristina Viera, Alejandro Bra\u00f1a, Aurora Astudillo, Dominique Heymann, Karoly Szuhai, Judith V.M.G. Bov\u00e9e, Agust\u00edn F. Fern\u00e1ndez, Mario F. Fraga, Javier Alonso and Ren\u00e9 Rodr\u00edguez. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2\" data-link=\"https:\/\/www.unioviedo.es\/IUOPA\/en\/a-personalized-medicine-approach-identifies-enasidenib-as-an-efficient-treatment-for-idh2-mutant-chondrosarcoma-2\/\"><h4 class=\"tagline\" style=\"color:#2f2f2f;\">Compartir noticia<\/h4><div class=\"fusion-social-networks sharingbox-shortcode-icon-wrapper sharingbox-shortcode-icon-wrapper-1\"><span><a href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.unioviedo.es%2FIUOPA%2Fen%2Fa-personalized-medicine-approach-identifies-enasidenib-as-an-efficient-treatment-for-idh2-mutant-chondrosarcoma-2%2F&amp;t=A%20personalized%20medicine%20approach%20identifies%20enasidenib%20as%20an%20efficient%20treatment%20for%20IDH2%20mutant%20chondrosarcoma\" target=\"_blank\" rel=\"noreferrer\" title=\"Facebook\" aria-label=\"Facebook\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-facebook awb-icon-facebook\" style=\"color:#76b5ae;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/twitter.com\/share?text=A%20personalized%20medicine%20approach%20identifies%20enasidenib%20as%20an%20efficient%20treatment%20for%20IDH2%20mutant%20chondrosarcoma&amp;url=https%3A%2F%2Fwww.unioviedo.es%2FIUOPA%2Fen%2Fa-personalized-medicine-approach-identifies-enasidenib-as-an-efficient-treatment-for-idh2-mutant-chondrosarcoma-2%2F\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Twitter\" aria-label=\"Twitter\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-twitter awb-icon-twitter\" style=\"color:#76b5ae;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/www.linkedin.com\/shareArticle?mini=true&amp;url=https%3A%2F%2Fwww.unioviedo.es%2FIUOPA%2Fen%2Fa-personalized-medicine-approach-identifies-enasidenib-as-an-efficient-treatment-for-idh2-mutant-chondrosarcoma-2%2F&amp;title=A%20personalized%20medicine%20approach%20identifies%20enasidenib%20as%20an%20efficient%20treatment%20for%20IDH2%20mutant%20chondrosarcoma&amp;summary=Ver%C3%B3nica%20Rey%2C%20Juan%20Torn%C3%ADn%2C%20Juan%20Jose%20Alba-Linares%2C%20Cristina%20Robledo%2C%20Dzohara%20Murillo%2C%20Aida%20Rodr%C3%ADguez%2C%20Borja%20Gallego%2C%20Carmen%20Huergo%2C%20Cristina%20Viera%2C%20Alejandro%20Bra%C3%B1a%2C%20Aurora%20Astudillo%2C%20Dominique%20Heymann%2C%20Karoly%20Szuhai%2C%20Judith%20V.M.G.%20Bov%C3%A9e%2C%20Agust%C3%ADn%20F.%20Fern%C3%A1ndez%2C%20Mario%20F.%20Fraga%2C%20Javier%20Alonso%20and%20Ren%C3%A9%20Rodr%C3%ADguez.%20A%20personalized%20medicine%20approach%20identifies%20enasidenib%20as%20an%20efficient%20treatment%20for%20IDH2\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"LinkedIn\" aria-label=\"LinkedIn\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-linkedin awb-icon-linkedin\" style=\"color:#76b5ae;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"mailto:?subject=A%20personalized%20medicine%20approach%20identifies%20enasidenib%20as%20an%20efficient%20treatment%20for%20IDH2%20mutant%20chondrosarcoma&amp;body=https%3A%2F%2Fwww.unioviedo.es%2FIUOPA%2Fen%2Fa-personalized-medicine-approach-identifies-enasidenib-as-an-efficient-treatment-for-idh2-mutant-chondrosarcoma-2%2F\" target=\"_self\" title=\"Correo electr\u00f3nico\" aria-label=\"Correo electr\u00f3nico\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-mail awb-icon-mail\" style=\"color:#76b5ae;\" aria-hidden=\"true\"><\/i><\/a><\/span><\/div><\/div><style type=\"text\/css\">.fusion-sharing-box-1 h4{margin-bottom:0 !important;}.fusion-sharing-box-1{flex-direction:row !important;padding-top:20px !important;padding-bottom:20px !important;}.sharingbox-shortcode-icon-wrapper-1 span.sharingbox-shortcode-icon-separator{border-right-width:0px !important;}@media only screen and (max-width:1024px){.fusion-sharing-box-1 h4{margin-right:0.5em !important;margin-bottom:0 !important;}.sharingbox-shortcode-icon-wrapper-1{width:auto !important;justify-content:flex-end !important;}.fusion-sharing-box-1{align-items:center !important;} }@media only screen and (max-width:640px){.fusion-sharing-box-1{flex-direction: column !important;align-items:center !important;}.fusion-sharing-box-1 h4{margin-bottom:revert !important;}.sharingbox-shortcode-icon-wrapper-1{width:100% !important;justify-content:space-between !important;} }<\/style><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-1{width:100% !important;margin-top : 0px;margin-bottom : 0px;}.fusion-builder-column-1 > .fusion-column-wrapper {padding-top : 20px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 20px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1024px) {.fusion-body .fusion-builder-column-1{width:100% !important;order : 0;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-1{width:100% !important;order : 0;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-2{ padding-top : 0px;margin-top : 0px;padding-right : 30px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 30px;}<\/style><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":1824,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[82],"tags":[162],"class_list":["post-3445","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications","tag-actualidad-iuopa-en"],"_links":{"self":[{"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/posts\/3445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/comments?post=3445"}],"version-history":[{"count":1,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/posts\/3445\/revisions"}],"predecessor-version":[{"id":3446,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/posts\/3445\/revisions\/3446"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/media\/1824"}],"wp:attachment":[{"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/media?parent=3445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/categories?post=3445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/tags?post=3445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}